High-performance liquid chromatography measurement of antimicrobial concentrations in polymorphonuclear leukocytes.
about
Antimycobacterial spectrum of sparfloxacin and its activities alone and in association with other drugs against Mycobacterium avium complex growing extracellularly and intracellularly in murine and human macrophagesIn vitro activity of the new difluorinated quinolone sparfloxacin (AT-4140) against Mycobacterium tuberculosis compared with activities of ofloxacin and ciprofloxacinActivity of topoisomerase inhibitors against Pneumocystis carinii in vitro and in an inoculated mouse modelPlasma concentrations of chloramphenicol after subcutaneous administration to koalas (Phascolarctos cinereus) with chlamydiosisIn vitro demonstration of transport and delivery of antibiotics by polymorphonuclear leukocytesInterference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?Azithromycin inhibition of intracellular Legionella micdadeiSimultaneous analysis of piperacillin and tazobactam in rabbits: application to pharmacokinetic study.Present and future therapeutic strategies for melioidosis and glanders.Clindamycin suppresses endotoxin released by ceftazidime-treated Escherichia coli O55:B5 and subsequent production of tumor necrosis factor alpha and interleukin-1 beta.Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society.Differential intracellular efficacies of ciprofloxacin and cefixime against Neisseria gonorrhoeae in human fallopian tube organ culture.Intraoperative concentrations of ofloxacin in serum, bile fluid, and gallbladder wall tissue.Comparative in vitro activities of ofloxacin, difloxacin, ciprofloxacin, and other selected antimicrobial agents against Brucella melitensis.Antibiotic penetration of and bactericidal activity within endothelial cells.In vitro and in vivo intraleukocytic accumulation of azithromycin (CP-62, 993) and its influence on ex vivo leukocyte chemiluminescence.Antibiotic pharmacokinetic and pharmacodynamic considerations in critical illness.Fluoroquinolones and tendon disorders.Lack of effective bactericidal activity of new quinolones against Brucella spp.Quinine uptake by human polymorphonuclear neutrophils.In vitro and in vivo ciprofloxacin pharmacokinetics in human neutrophils.The intracellular accumulation of phagocytic and epithelial cells and the inhibitory effect on Chlamydophila (Chlamydia) pneumoniae of telithromycin and comparator antimicrobials.Assessment of florfenicol as a possible treatment for chlamydiosis in koalas (Phascolarctos cinereus).Isoniazid: A Review of Characteristics, Properties and Analytical Methods.Effects of enrofloxacin on porcine phagocytic function.Mechanism of therapeutic effectiveness of cefixime against typhoid fever.Entry of sanfetrinem into human polymorphonuclear granulocytes and its cell-associated activity against intracellular, penicillin-resistant Streptococcus pneumoniae.Interactions between HMR 3647, a new ketolide, and human polymorphonuclear neutrophils.Uptake and intracellular activity of NM394, a new quinolone, in human polymorphonuclear leukocytes.Penetration of brodimoprim into human neutrophils and intracellular activity.Uptake and intracellular activity of AM-1155 in phagocytic cells.In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection.Uptake and intracellular activity of an optically active ofloxacin isomer in human neutrophils and tissue culture cells.Intracellular activity of tosufloxacin (T-3262) against Salmonella enteritidis and ability to penetrate into tissue culture cells of human origin.Fluorometric measurement of ofloxacin uptake by human polymorphonuclear leukocytes.Efficacy of NY-198 against experimental Legionnaires disease.Accumulation of a newly developed fluoroquinolone, OPC-17116, by human polymorphonuclear leukocytes.The determination of the cellular volume of avian, porcine and bovine phagocytes and bovine mammary epithelial cells and its relationship to uptake of tilmicosin.Treatment of the Fluoroquinolone-Associated Disability: The Pathobiochemical Implications.
P2860
Q28322331-B354F3CC-880A-4839-BFA3-E375858DAEECQ28333965-27674A1D-5DCC-4A78-AD7B-E26744129D2EQ28378635-39B9AF38-ECC7-4E32-8B13-0E125A04D370Q29398804-B0A98325-0881-4F69-8445-E64493FB53CCQ30311321-C701708A-8153-483D-951A-B33E1225078FQ30327329-D4C50580-3A61-4FD2-8E8F-3C5E73E84C01Q30451684-857CA979-EC0F-4333-8428-21BF09E0E420Q31120731-5673C4F5-C3A9-40F8-B127-86B0B6C460D5Q33797791-8B540BDF-5EC9-4E3F-926F-BC1A344171E2Q33976461-DC97BE7C-F6C1-45FC-B4DC-3DEC46A57121Q34708209-6E03562D-60CD-4095-998B-C6304C617E60Q35137211-18694DE3-982D-4ACA-BC50-8771FE04EE39Q35285078-14553F72-76BE-4DA8-8D9D-B530EF4710D9Q35346446-5FEDABF1-77A2-4D45-BF24-F22E1EA1EA6DQ35820549-55754221-5E50-4B77-A557-82537A40ED10Q35862819-5F6F2C43-CE42-4397-B7A4-3DA97DD594A8Q35944927-1B047B0F-07F7-4BFC-83FC-F179DFBBDEA9Q36082020-E55863E7-3CDA-4D68-BAE1-941D313F002AQ36753441-2E44F0BE-F867-4AFC-A8C2-095893F2843FQ36754287-C4FABCC2-D7BF-431F-A00F-67D79A59F93FQ36756519-C1335382-8E7E-4171-852A-0ACEB485E51BQ37856896-4628D21A-B63C-468C-9A51-7EA09BDB7C8BQ38606119-CD0C406C-E38C-41A6-9F40-74779988ED6FQ39083469-DB370FB0-741D-4AE5-9806-881248EEC3F6Q39471666-7623FC4E-FBC8-401E-8015-DBCFD5A72DE8Q39478164-25034E88-2F60-4DE8-AAFE-009128A1393FQ39558038-3C8DE9FF-E6D3-47E4-98AE-7BA53B5E041CQ39558233-B6C5B3D6-C29E-4AF6-864B-330349E69048Q39781680-A074CC13-5751-4127-A476-A3E63F87F203Q39782989-EAAD9398-ABDA-4A06-959A-05C80AF43918Q39783263-56766CB1-0471-4B51-92BF-2E8CB7BBECBEQ39815023-465618F5-239B-4A04-80C9-613D7850DD9FQ39815370-5D9B53CA-F6D9-4ADD-B946-9C9366C57E57Q39816058-C43520B6-EECF-4252-AC88-DCA66513A55BQ39819180-32D76926-1F71-4E5E-B802-EDA9D21B9468Q39832353-73499604-51B0-4132-8171-01C3BBF471D1Q39866608-936DA6DC-EB5C-4DEB-925A-60C107A39FC5Q40959450-C919974E-5DA9-4171-981E-DC20A8496F1BQ45180659-87929355-CEB4-4B94-8DFA-99CEF197DC45
P2860
High-performance liquid chromatography measurement of antimicrobial concentrations in polymorphonuclear leukocytes.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
High-performance liquid chroma ...... polymorphonuclear leukocytes.
@en
High-performance liquid chroma ...... polymorphonuclear leukocytes.
@nl
type
label
High-performance liquid chroma ...... polymorphonuclear leukocytes.
@en
High-performance liquid chroma ...... polymorphonuclear leukocytes.
@nl
prefLabel
High-performance liquid chroma ...... polymorphonuclear leukocytes.
@en
High-performance liquid chroma ...... polymorphonuclear leukocytes.
@nl
P2860
P356
P1476
High-performance liquid chroma ...... polymorphonuclear leukocytes.
@en
P2093
P2860
P304
P356
10.1128/AAC.31.12.1904
P407
P577
1987-12-01T00:00:00Z